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COMPARISON OF EXTRACTION TECHNIQUES FOR 
~-9-TETRAHYDROCANNABINOL FROM URINE 
by Ashlyn Christine Harmon 
May 2010 
With the increasing use of marijuana, efficient methods to extract and detect ~-9-
THC in urine samples and relate the concentrations found to time is a necessity so that 
impairment can be determined. ~-9-THC is conjugated to glucuronic acid in urine and 
must be freed before the compound can be detected by chromatographic procedures. In 
past research, either a strong alkaline solution or p-glucuronidase has been used to cleave 
the bond between the ~-9-THC and glucuronic acid before an alkaline extraction. ~-9-
THC has a pKa of 10.6 and therefore is always extracted at an alkaline pH. In this study, 
both a strong solution ofNaOH and the enzyme were used to break the glucuronide bond 
in urine samples and the result obtained from each compared. This research first looked 
at the best treatment for the glucuronide bond and secondly, determined if the extraction 
could be completed at an acidic pH and still yield expected results. Fifty urine samples 
from known marijuana users were treated with NaOH and extracted at an alkaline pH; the 
same 50 samples were also treated with p-glucuronidase and extracted at an acidic pH. 
The results from this part of the experiment showed that not only did the NaOH not work 
as well as the enzyme, it did not cleave the bond at all. In order for a determination to be 
made about the pH ofthe extraction, the same 50 samples were all treated with P-
glucuronidase and then made alkaline before extraction. For the two extractions using P-
glucuronidase, t (.05) ( IOO) = 0.283 for the height and t (.05) ( IOO) = 0.277 for the area. The 
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two extractions were proved to not be significantly different. The concentrations of ~-9-
THC in each sample were determined for both extractions. The t ratio for the 
concentrations was calculated and again determined to not be significantly different; 
t (05) ( tOO) = 0.241 which fell well below the acceptable value of significance. 
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Forensic toxicology is the application of toxicology for legal purposes (Levine, 
2006). The analysis of drugs and other toxic substance along with the determination of 
their concentrations in biological samples constitutes the basis for this discipline of 
toxicology. There are three major sub-disciplines that comprise forensic toxicology: 
post-mortem forensic toxicology, human performance toxicology, and forensic drug 
testing. In all of these disciplines, toxicology is used in combination with other fields of 
chemistry such as analytical and clinical chemistry as well as pharmacology to determine 
if, first, a toxic substance is present and secondly, if it is in a concentration high enough 
to have caused intoxication or death. 
In forensic toxicology, the extraction of the toxic substances from the biological 
sample is the primary step in the qualitation and/or quantitation of any toxin(s) present. 
This step is especially important to the process of determining if a toxin is present and if 
so, its concentration, because the method chosen for analysis must be appropriate for the 
toxin(s) to be extracted. 
Extraction methods for analysis of biological samples for drugs can be done in 
one of the two primary ways. Drugs are extracted from a sample by using liquid-liquid 
extractions or by using solid-phase extractions. Both of these techniques have positive, 
as well as negative qualities associated with them. The use of one versus the other is a 
choice that an analyst must make depending on what drug is to be extracted and other 
issues concerning time and effectiveness. 
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Liquid-liquid extractions have been in use since the 1850s and have many 
problems associated with them (Levine, 2006). The basis for this extraction technique is 
the use oftwo immiscible liquids, water and an organic solvent. Liquid-liquid 
extractions can be either basic or acidic depending on the pKa of the drug to be extracted. 
To determine the pKa of the drug, the Henderson-Hasselbach equation should be used 
(Levine, 2006). Once the appropriate pH is determined for extraction, a buffer can now 
be selected for the extraction process. 
As with most analyses, the first step of extraction is selecting a certain volume of 
the sample to extract. This is dependent on the initial volume given to an analyst and the 
drug in question. An aliquot should be placed in a clean test tube and the selected buffer 
added. The solution of buffer and sample must be vortexed to thoroughly mix the two. If 
a quantitation of the drug is desired, an appropriate internal standard should now be 
added to the tube and vortexed. The next step in this process is the adding of an 
extraction solvent. The solvent to be used is dependent upon the polarity and the type of 
drug to be extracted from the sample. The specific gravity of the solvent should also be 
considered when choosing an extraction solvent because this property will determine the 
orientation of the solvent to the aqueous layer after centrifugation. Once this solvent is 
added to the solution, the tubes are placed on a rotator for a period of time so that the 
extraction solvent will mix with the sample and extract the drug. When the extraction 
time is finished, the tube is centrifuged to separate the organic and aqueous layers. The 
organic layer should be removed and placed into a new, clean test tube. The organic 
solvent is now dried down so that the drug can be concentrated by dissolving in a smaller 
volume of solvent. 
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When a biological sample is extracted, the drug is not the only component of the 
sample extracted. Other interfering compounds found in biological fluids, will also be 
extracted. These interferences can be minimized, but not completely removed by using a 
back extraction technique. This technique is an alteration of the normal liquid-liquid 
extraction and is more time consuming and tedious. 
Liquid-liquid extractions are fairly easy to complete, but can be somewhat time 
consuming especially if a back extraction is necessary; back extractions are primarily 
used for basic drugs/toxins. The normal process of liquid-liquid extractions is not quick 
to begin with, but if a back extraction is required, the process is doubled in time and 
material. A back extraction is completed by beginning in the same way as a normal 
liquid-liquid extraction. The back extraction proces~ starts when then organic solvent is 
transferred to a new test tube. The organic solvent is not dried down, but when extracting 
basic drugs an acid is added to the solvent to precipitate out the drug from the organic 
solvent. Many ofthe interfering substances are left behind in the organic solvent. The 
solvent is now discarded. A buffer is added to the aqueous phase to make it basic once 
again. The process now continues like the normal liquid-liquid extraction with the 
organic layer being removed from the test tube and dried down so that the drug residue 
can be concentrated. 
With a liquid-liquid extraction, the greatest loss of recovery happens during the 
first partitioning of the aqueous and organic extraction solvent. Seventy percent or 
greater recovery can be expected (Levine, 2006). This percentage of recovery is apt to be 
lower with the process of a back extraction. This is due to the multiple extractions with 
loss of drug during each step. While back extractions are one of the more useful 
techniques of liquid-liquid extractions, it does not solve all problems that occur with this 
technique. 
Solid phase extractions (SPE) were first used in 1965 as an alternative extraction 
method. Since then, SPE has undergone many improvements. SPE was designed by 
scientist because of the many drawbacks and problems associated with liquid-liquid 
extractions (Levine, 2006). SPE uses a stationary phase (column made of silica) which 
has an affinity for desired compounds in the liquid sample. It also uses the principle of 
affinity to discriminate against interferences based on their physical and chemical 
properties. 
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The process of SPE starts by conditioning the stationary phase made of various 
chemical components based on the extraction to be conducted. The first step of this 
process is wetting the column with water and then methanol. The sample can now be 
added to the column. This sample can be either "pushed" through the column using 
positive pressure, or "pulled" through using negative pressure. The sample will settle 
through out the column. A critical step is how fast the sample flows through the column; 
too fast results in loss of drug and too slow increases the amount of interferences. 
Theoretically, the wanted compounds will adhere to the column and the unwanted 
interferences can be washed out using an organic solvent. Once the interferences are 
removed, the drugs can be eluted by using a buffered organic solvent. 
Since SPE does not usually use whole blood, like liquid-liquid extractions, the 
problem of interferences is greatly reduced, but is not completely removed. SPE is 
difficult when using whole blood because of the occurrence of clots and other particulate 
matter that will clog the column and prevent the flow of sample or solute through the 
column (Levine, 2006). If an SPE column becomes clogged, it is of no further use and 
must be discarded. This issue with SPE is especially difficult when dealing with 
postmortem blood samples, given the often limited amount of sample received. 
Other issues faced with SPE include the time spent washing and conditioning the 
columns. Extractions using SPE use different volumes of solvent and other materials 
involved and therefore require more time and effort from an analyst than does other, 
more simple extraction processes (Siek, 2006). 
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Extractions like the ones discussed here are preliminary steps in the actual 
analysis of drugs from biological samples. These extractions only aim to purify and 
isolate the drug from the sample so that it can be further tested by other instrumentation. 
The gas chromatograph/mass spectrometer (GC/MS) is considered the gold standard for 
the analyses of drugs from biological samples. GC/MS is the best means of confirming a 
drug 's identity. The GC/MS does encounter problems when the sample has not been 
purified enough by the extraction method and interferences are still present in the final 
product. Interferences cause problems both with the chromatography ofthe instrument 
and identification of analytes. If enough ofthese interferences build up in the column of 
the instrument, the column becomes inefficient for separation of analytes and a portion 
must be cut off. If nothing is done to correct this problem, the peaks produced by the 
GC/MS will become distorted from their proper Gaussian shape. This altered shape of 
the curves produced may result in an incorrect reading in the concentrations of the drug 




REVIEW OF LITERATURE 
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Cannabis sativa, or marijuana, has been used by man for more than 4000 years 
for many different purposes. Throughout history, one of the varieties of the plant that has 
little or none of the psychoactive compound has been used for food and its fiber used to 
make various items. The fiber from the marijuana plant is referred to as hemp fiber and 
was used to make clothing and rope for sails. This variety of the Cannabis sativa plant is 
more cane-like which yields more of the hemp fiber than other varieties of the plant 
which are grown for their psychoactive compound (Huestis, 2006). Today, the seeds 
from the plant can be sterilized to remove their psychoactive properties and used in 
animal feed (Carroll, 1993). 
The cannabis plant is indigenous to in Central Asia and was used by people in 
China and India for medicinal purposes. These medical purposes included using 
marijuana to treat problems such as rheumatism, muscle spasms, epilepsy, convulsions, 
asthma, and for the purpose of relieving pain (Huestis, 2006). The use of marijuana to 
treat migraines, stimulate appetite, and help with sleep disorders has also been noted as 
medical uses for the drug (Bums, 2003). Marijuana was even discovered to have been 
used by the Egyptians to help ease the pain associated with child birth. The use of 
marijuana in European counties for medical purposes began in 1842, but was eventually 
stopped due to there being no way to determine the potency of the dose, thus treatments 
were not always successful (Huestis, 2006). 
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Marijuana is not native to North America, but was brought over by the early 
settlers in the 1600's who used the plant for hemp. Cannabis was the first cash crop to be 
grown in Massachusetts (Carroll, 1993). The government actually required farmers to 
grow marijuana because ofthe use of its fiber. Marijuana was an important part of 
agriculture in America and its production was only exceeded by cotton. The 
psychoactive properties of the plant were known during this time, but the public did not 
recreationally use the drug (Carroll, 1993). Marijuana remained to be a vital part of 
agriculture in America until the invention of the cotton gin and the ability to import hemp 
at a lower cost from other countries eventually caused its growth as a cash crop and 
production to be greatly reduced (Drug ID Bible, 2006). 
Marijuana started being used in Western medicine during 1839 and continued to 
be used medically for the next 100 years. During this time period, pharmaceutical 
companies produced 28 different preparations of marijuana. These 28 preparations were 
used to treat many different medical problems ranging from insomnia to menstrual 
cramps. In 1935, marijuana abuse led to the Marijuana Tax Act of 1937. This act did not 
outlaw marijuana, but imposed heavy taxes on farmers who cultivated the plant. Shortly 
thereafter, all 28 ofthe preparations were removed from the market. Due to the tax act, 
marijuana growth and production virtually stopped and the United States was reliant upon 
the import of hemp fiber from Japan. However, due to World War II, Japan cut off the 
supply of hemp to the U. S. Americans were now allowed to, and encouraged to, grow 
marijuana for the production of hemp until the war was over in 1945 (Drug ID Bible, 
2006). 
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In the years after WWII to current times, marijuana abuse has continued to be an 
issue in the United States. The use of marijuana as a recreational drug became popular in 
the 1960's like many other drugs of abuse. It continues to be the most used illegal drug 
today (Burns, 2003). Recently, many countries including Canada and England have 
began to allow farmers to grow marijuana for the production of hemp fiber so that it can 
be used to make things like paper, rope, and textiles. This variety of marijuana is referred 
to as industrial hemp and contains 0.05-1.0% of the psychoactive ingredient. In the 
United States today, a few cancer, AIDS, and glaucoma patients have been given 
government permission to legally smoke marijuana to help ease the pain associated with 
their condition (Drug ID Bible, 2006). Some of these patients are even prescribed 
Marinol which is a preparation of the main psychoactive component found in marijuana 
(Burns, 2003 ). Debates about the legalization of marijuana for medicinal purposes still 
continue today. 
Metabolism 
Marijuana contains 61 cannabinoids of which one, ~-9-Tetrahydrocannabinol (~-
9-THC) (see Fig. 1) produces almost all of the psychoactive effects. ~-9-THC is 
responsible for the behavioral and physiologic effects caused by marijuana. This 
compound is found in the cannabis plant' s leaves and flowering regions. ~-9-THC is a 
tricyclic, 21-carbon compound that contains a phenol group; its molecular formula is 










Figure 1. ~-9-Tetrahydrocannabinol 
These effects of ~-9-THC are described as feelings of euphoria, but also include 
impaired memory, lack of concentration, and paranoia. Increased appetite and heart rate 
are among some of the more common physiological effects ·experience by users . ~-9-
THC is difficult to classify because it affects different individuals in different manners. It 
is cannot be placed in one of the main categories of drugs (stimulants, tranquilizers, 
sedatives or hallucinogens) definitely due to its wide range of effects on different users 
(Huestis, 2006). 
Marijuana is a central nervous system depressant at high doses and acts upon a 
user through cannabinoid receptors in the brain. Marijuana is usually ingested by 
smoking due to the quick and efficient delivery of the drug from the lungs to the brain, 
although it can be used via oral route. ~-9-THC has a bioavailability ranging from 18-
50%, when smoked, and ranging from 6-18% when orally ingested. Absorption of the 
drug when orally ingested, versus smoking, is slower which makes smoking the usual 
method of choice because the user feels the effects almost immediately, although the 
effects last longer when ingested orally (Huestis, 2006). When the drug is ingested 
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orally, much of it is broken down in the stomach which accounts for its low 
bioavailability. ~-9-THC is quickly metabolized when used orally so the effects felt are 
due to the ~-9-THC and its active metabolite, 11-0H-THC. 
~-9-THC is highly lipophilic; this accounts for its distribution in fat and its long 
half-life in the body. ~-9-THC is readily metabolized in the body to two metabolites due 
to its lipophilic nature, one being an active metabolite and the other inactive (Kemp, 
1995). Users may actually be impaired while his or her ~-9-THC will be very low or 
non-detectable due to the quick metabolism of ~-9-THC by the body. Once ~-9-THC 
enters the body through smoking marijuana or through oral ingestion, it undergoes 
hydroxylation of the methyl group attached to the eleventh carbon ofthe structure by on 
of the P450 enzymes which causes the production of the active metabolite, 11-hydroxy-
tetrahydrocannabinol (11-0H-THC). 11-0H-THC is then further oxidized to 11-Nor-~-
9-THC-carboxylic acid (THC-COOH), which is the major, but inactive, metabolite found 
in urine and blood. THC-COOH is conjugated to glucuronide (see Fig. 2) in urine and is 
the main end product in the metabolism and excretion of ~-9-THC. After a user is has 
ceased smoking, THC-COOH levels in urine will gradually reach and eventually surpass 
the level of ~-9-THC in urine. This process is slow because the THC-COOH is polar and 
is not rapidly cleared from the blood due to protein binding (Huestis, 2006). 
HO 








""" -r---0 OH 
Figure 2. Glucuronic Acid 
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Around 20% of 6-9-THC's metabolites are excreted in the urine. During the first 
5 days after use, a large portion of the drug is excreted from the body as THC-COOH and 
11-0H-THC, with the urine containing mostly the THC-COOH. THC-COOH is 
conjugated to glucuronic acid to promote water solubi lity so that it can be more easily 
excreted. These conjugated metabolites have been identified in urine and are thought to 
be key indicators of time period since the user ingested marijuana (Kemp, 1995). During 
analysis of urine for THC-COOH, this glucuronide bond must first be broken so that the 
THC-COOH or other metabolites can be detected and quantitated. 
Determining Elapsed Time from Concentrations of6-9-THC and Its Metabolites 
With the increased use of marijuana, methods for determining if an individual is 
under the influence of marijuana has also become a priority. Since it is known that 6-9-
THC is rapidly converted to its daughter metabolites, high levels of the parent drug 
would indicate recent use. In theory, the higher the ratio of the concentration of 6-9-
THC to its metabolites, the more recent an individual used marijuana. Experiments have 
been conducted that monitor the time since marijuana use and compare these times to the 
ratio of 6-9-THC concentration to its metabolites' concentration in either urine or 
plasma. By doing so, investigators are able to predict when an individual last used 
marijuana and, therefore, determine if an individual is under the influence of the drug. 
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One previous study (Huestis et al., Blood Cannabinoids I, 1992) that tests the 
above theory was performed using 6 volunteer males who either regularly or occasionally 
used marijuana. These individuals were all thoroughly examined to ensure that they were 
in good health. Each volunteer was given a drug test for not only ~-9-THC, but for other 
drugs of abuse before the beginning of the study to ensure the accuracy of the results 
obtained. 
The marijuana cigarettes were obtained from the National Institute on Drug 
Abuse and contained 0.0%, 1.75%, or 3.55% ~-9-THC. The administered amount of~-
9-THC to an individual was random. A computer was used to monitor the smoking to 
ensure that each of the individuals inhaled the smoke, held it in, and exhaled for the same 
length of time for the purpose of consistency. Eight inhalations were taken by each 
individual throughout the smoking process. 
During the smoking process, 10 blood samples were taken from each participant 
at 1 minute intervals. After smoking, samples were taken at increasingly spaced intervals 
which gave 34 total samples over the time of7 day. All blood samples were centrifuged 
to provide plasma which was stored frozen until analysis. Analysis ofthe samples was 
completed using capillary gas chromatography in combination with negative chemical 
ionization mass spectrometry. 
The results from the experiment showed that ~-9-THC immediately entered the 
blood stream after the first inhalation of marijuana. Concentration of ~-9-THC steadily 
rose during the smoking process with a mean value of7.0 ng/mL for individuals who had 
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smoked the cigarette containing 1.75% ~-9-THC, and 18.1 ng/mL for participants who 
had smoked the marijuana cigarette containing 3.55% ~-9-THC. The mean peak 
concentration of ~-9-THC was found to be 84.3 ng/mL and 162.2 ng/mL, respectively. 
After 2 hours, the levels of ~-9-THC found in plasma had dropped to 5 ng/mL or below. 
However, the presence of ~-9-THC did remain detectable for up to 12 hours by GC/MS, 
where the limit of detection was 0.5 ng/mL. 
Analysis ofthe plasma samples for the two metabolites of ~-9-THC was 
conducted to obtain ratios of the concentration of the parent drug to the concentrations of 
its metabolites at various time intervals. 11-0H-THC, the first metabolite to form during 
metabolism of ~-9-THC, was only detected in the plasma of one of the subjects after the 
initially, but was detected in the plasma of three of the subj~cts after the third inhalation. 
During the first 45 minutes after the start of smoking, the concentration of 11-0H-THC 
remained in the range of 6-10% of the concentration of the ~-9-THC. Mean peak levels 
of6.7 ng/mL and 7.5 ng/mL 11-0H-THC occurred 13.5 minutes after the start of 
smoking. Even though the concentration of 11-0H-THC started to fall , the ratio of [11-
0H-THC]/[ ~-9-THC] began to increase after this time period due to the more rapid fall 
ofthe ~-9-THC concentration in the plasma samples. 
The second metabolite, THC-COOH, which is formed from the initial metabolite 
11-0H-THC, appeared later in the plasma samples, as expected, but gradually rose, 
plateaued then dissipated slowly. THC-COOH was not detected in all 6 of the subject' s 
plasma until 8 minutes after the first inhalation. The peak concentrations for THC-
COOH were much higher than those for the 11-0H-THC; 24.5 ng/mL and 54 ng/mL 
were the mean peak concentrations of THC-COOH for the low and high doses of ~-9-
THC, respectively. THC-COOH was detectable for a mean time period of 84 hours for 
the low dose of 6-9-THC and for 152 hours for the higher dose. 
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The results of this research performed by Huestis demonstrates that after an 
approximate time of 13.5 minutes from the initial inhalation ofthe marijuana cigarette, 
the 6-9-THC levels decrease while the concentration of THC-COOH increases and 
plateaus before it begins to gradually drop. The 11-0H-THC concentrations are shown to 
peak early and drop quickly as compared to the THC-COOH. This means that the use of 
a 11-0H-THC: 6-9-THC ratio for determining the time since a user ingested the drug by 
inhalation would only be applicable during the first 2.5 hours after ingestion. The use of 
a THC-COOH/ 6-9-THC ratio to determine time since ingestion of marijuana by 
smoking would be of more value due to the lingering nature ofTHC-COOH in the body. 
A second study also conducted by Huestis et al. , (Blood Cannabinoids II, 1992) 
used the data and information obtained in the study above (Huestis et al. , Blood 
Cannabinoids II, 1992). The data from the samples taken during the process was used to 
construct mathematical models for the purpose of prediction of time intervals since 
marijuana use. 
Two models were derived from this data. The first of the models, Model I, uses 
the relationship between the concentration of 6-9-THC and the time elapsed after 
smoking while the second model, Model II, uses the ratio of THC-COOH to 6-9-THC 
and time. Both models were formed using linear regression analysis. Model I states: 
Log (T) = m * log [THC] + b 
T represents the predicted time after marijuana use and [THC] is the concentration of 6-
9-THC quantitated in units of ng/mL. m is slope of the line, and b represents the y-
intercept. Model II was derived similarly, but used both the concentration ofthe ~-9-
THC and its metabolite, THC-COOH, to form a working equation. Model II is as 
follows: 
Log (T) = m * log [THCCOOH]/[THC] + b 
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Like Model I, Tis representative of predicted time since marijuana ingestion, m is slope 
and b is they-intercept. The only difference between the two models is the use of the 
ratio between THC-COOH concentration and the concentration of ~-9-THC, and not just 
the concentration of ~-9-THC. 
Data from prior controlled experiments were used to test the accuracy of the 
models. This data was obtained from users who had ingested marijuana in many ways, 
including inhalation and oral ingestion; only data with concentrations of2 ng/mL or 
higher were used. The accuracy of both models was tested in two ways. 
First, by using absolute time error where the actual time elapsed was subtracted 
from the predicted time elapsed and the absolute value taken. The models were also 
tested for accuracy by comparing actual time after marijuana use to a 95% confidence 
interval. 
For Model I, the absolute time error when evaluating data from 238 plasma 
samples from individuals who do not use marijuana frequently was 0.45 hours and when 
actual time was compared to the 95% confidence interval, 221 samples fell within the 
limits. Model I's predictability was also assessed using samples from subjects who used 
marijuana regularly. Using ten of these plasma samples, Model I showed to have an 
absolute time error of 0.17 hours and all ten of the predicted times using Model I fell with 
in the 95% confidence interval. 
16 
The absolute time error and confidence interval for Model II was calculated using 
233 plasma samples from individuals who only occasionally used marijuana. The 
absolute time error for Model II was 0.51 hours and 209 of the samples fell within the 
95% confidence interval. Model II was also tested using plasma samples from 
individuals who used marijuana regularly. The absolute time error for Model II was 
found to be 1.1 hours and only ten out of 14 samples used fell within the 95% confidence 
interval. 
Three other studies, including one where the subjects orally ingested marijuana, 
were also conducted to test the validity of the two models. Only one of all the studies 
conducted, in which plasma samples from ten infrequent marijuana users were analyzed, 
failed to demonstrate the predictability of the two models for time of ingestion. In this 
study, the absolute time error for Model I was 1.05 hours and for Model II was 1.31 
hours. Also, out of 84 samples, Model I only had 33 samples fall within the 95% 
confidence interval and Model II had only 30 actual exposure times fall within the 
confidence interval. While inaccurate, the predicted times of smoking exposure for both 
models were consistently low. The lack of accuracy of the models in this study was 
determined to be due to the lack of consistency in the smoking procedure. 
Studies such as the ones noted here provide important information that can be 
especially useful for forensic toxicologist when interpreting information from case 
samples. Being able to accurately predict the time since someone has smoked marijuana 
is especially useful when deciding if the drug did, in fact, contribute to a car accident or 
any other situation in question by legal authorities (Huestis et al., Blood Cannabinoids II, 
1992). 
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Similar, more recent research (Manno et al. , 2001) was completed that also 
studied the relationship between time after smoking marijuana and the concentration of 
1),-9-THC and its two main metabolites 11-0H-THC and THC-COOH. Like the method 
noted above for determining an approximate time after marijuana use, researchers here 
used a time to concentration relationship, but included another metabolite of 1),-9-THC, 
8~ , 11-dihydroxy-THC, in their research. 8~ , 11-dihydroxy-THC is known to be 
eliminated in urine during the 24 hours following use of the drug and was thought to be a 
possible indicator for recent marijuana use, but was not proven useful in this study. 
Manno et al. (200 1) then focused primarily on the concentrations of 1),-9-THC and 
11-0H-THC because both analytes are pharmacologically active. Using the inactive 
metabolite, THC-COOH, can help establish a time since use, but because it is inactive, no 
relationship between it and human performance can be made. By using the active parent 
analyte, 1),-9-THC, and its active metabolite, 11-0H-THC, not only can time since 
marijuana use be determined, but also an interpretation of impairment can be made. 
THC-COOH was analyzed during this study; it just was not the primary analyte of 
interest. 
Eight individuals with a history of occasional marijuana use were selected as 
subjects for this experiment and evaluated for both physical and mental health. This 
group of eight consisted of four females and four males. Each person was given a drug 
screen for illicit drugs and breath test for ethanol on test days prior to the start of the 
experiment. Female volunteers were also given pregnancy test before each experiment. 
Marijuana cigarettes were obtained from Research Triangle Institute and 
contained 0.0 %, 1.77 %, or 3.58% 1),-9-THC. Doses to individuals were chosen at 
random. A computerized program was used to ensure uniformity during the smoking 
process. Time spent inhaling, holding, and exhaling by the individuals was controlled. 
Plasma samples from the subjects were collected prior to the start of smoking, 5.0 
minutes after smoking, and every hour for 8 hours after the smoking process. The 
samples were placed in glass culture tubes and stored frozen until analysis. 
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The preparation and extraction process used for these plasma samples was 
completed by a method previously determined by Kemp, et al. (1995). Bacterial ~­
glucuronidase from E. coli was used to hydrolyze the glucuronide bonds of the analytes. 
The matrix was then extracted at an acid pH with a solution of hexane and ethyl acetate 
(7: 1) and quantitated via GC/MS following derivatization. 
~-9-THC concentrations in the plasma samples were the highest within the first 
5.0 minutes after smoking. The peak concentrations for ~-9-THC were shown to be dose 
dependent. Samples from subjects who had been given the 1.77% ~-9-THC marijuana 
cigarette had a mean peak concentration of 13.4 ng/mL +/- 3.9 ng/mL. The mean peak 
concentration for subjects who smoked the marijuana cigarettes with 3.58% ~-9-THC 
was 33.6 ng/mL +/- 6.2 ng/mL. Within just the first hour, however, the mean 
concentrations of ~-9-THC had fallen to 5.5 and 2.5 ng/mL for the high and low dose, 
respectively. 
The active metabolite, 11-0H-THC, plasma concentration peaked at 5.0 minutes 
after smoking. The mean concentrations for the low and high dose of ~-9-THC were 2.6 
ng/mL +/- 0.9 ng/mL and 8.3 ng/mL +/- 2.1 ng/mL, respectively. Concentrations for 11-
0H-THC fell to approximately half their mean peak value 1 hour after smoking. 
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Mathematical models previously derived by Huestis et al. (Blood Cannabinoids II, 
1992) were tested for accuracy using the data obtained during this experiment. Model I 
and Model II were tested by using the 95% confidence interval. When used with the data 
from this experiment, Model I predictions fell within the confidence interval. The 
predicted times, however, were consistently overestimated before the 2 hour mark and 
underestimated after the 4 hours after marijuana use. Model I produced predicted times 
that were acceptable for a 95% confidence interval and was validated accordingly. 
Model II also produced estimated times since marijuana use that were acceptable 
for a 95% confidence interval. When using Model II, 24 of25 times predicted fell within 
the acceptable range. Elapsed times since marijuana use were consistently overestimated 
throughout the entire time period analyzed which gives it a high bias and makes it 
appealing for legal purposes. 
Urine samples from the subjects were also analyzed during this study. il-9-THC 
levels in urine did not peak until 2 hours after smoking. il-9-THC concentrations did not 
fall below the limit of detection in urine until 5 hours after smoking for the 1. 77% il-9-
THC dose and 7 hours for the 3.58% il-9-THC dose. Using the 2 ng/mL threshold, il-9-
THC concentrations could be quantitated for up to 5 hours after smoking for the high 
dose of il-9-THC. For any concentration greater than 2 ng/mL in a urine sample, it could 
be determined that an individual had used marijuana within the past 5 hours which is 
within the time period that human performance is impaired. 
11-0H-THC concentrations peaked around 3 hours after smoking, gradually 
dropped, but never fell below the limit of detection for the entirety of the experimental 
process. At the peak concentration, the mean for the low dose was 48.7 ng/mL+/- 11.5 
ng/mL and the mean for the high dose was found to be 77.3 ng/mL+/- 29.7 ng/mL. 11-
0H-THC concentrations declined more slowly than did the L\-9-THC concentrations in 
the urine as well as in the plasma samples. 
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L\-9-THC and 11-0H-THC concentrations as markers for time since marijuana 
use were determined to be useful. It was determined that urine concentrations of L\-9-
THC greater that 2 ng/mL were indicative of marijuana use within the past 5 hours which 
means that the individual was impaired by the drug within this time frame. Mathematical 
models for prediction of elapsed time since marijuana use previously derived by Huestis 
et al. (Blood Cannabinoids II, 1992) were verified using the data from plasma samples 
gathered during this experiment. It was also found during this study that 8P-dihydroxy-
THC concentrations could not be used as an indicator for time since marijuana use, as 
previously established. 
The above noted research uses plasma or urine samples from individuals who 
have ingested marijuana by smoking to determine relationships between concentrations 
of L\-9-THC and its metabolites and the time that had elapsed since an individual last 
used marijuana. One study, (Kelly & Jones, 1992) however, looked at the relationship 
between concentrations and time after individuals were given intravenous injections of L\-
9-THC. This method also differed from the prior noted methods of time determination in 
that the researchers included a comparison of conjugated and unconjugated THC-COOH. 
Plasma samples were collected at various time points throughout the injection 
process, stored frozen, then analyzed and quantitated for L\-9-THC and THC-COOH. In 
one set of plasma samples, the glucuronide bond was hydrolyzed by using 10 N NaOH; 
in the other set, no method for hydrolyzing the glucuronide bond was performed. By 
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treating the samples in such a manner, the concentration of unconjugated THC-COOH 
could be subtracted from the total concentration of THC-COOH and the concentration of 
conjugated THC-COOH determined. Before extraction, the plasma samples were made 
acidic using 0.05 M H3P04 and further adjusting the pH to 3-4 with glacial acetic acid. 
The plasma samples were extracted using solid phase extraction, derivatized 
trifluoroacetic anhydride, and analyzed via GC/MS. Urine samples collected from the 
same individuals were extracted, derivatized, and analyzed identically to the plasma 
samples. 
The ratio of free THC-COOH to conjugated THC-COOH greater than 2 only 
occurred between the elapsed time of 2 and 30 minutes. After the 30 minute mark, all of 
the ratios had dropped below 2 until negligible. Using a ratio. of free THC-COOH to 
conjugated THC-COOH would not be of use after the 30 minute mark. 
Researchers then turned to a previous method for time indication of marijuana use 
that used a ratio oftotal THC-COOH, both conjugated and free, and 8.-9-THC (Law et 
al., 1984 ). In this previous work decided a ratio less than 20 for THC-COOH to 8.-9-
THC was indicative of recent marijuana use. The study conducted by Kelly and Jones 
(1992), however, made an even more specific determination and stated that use within the 
last 45 minutes would yield a ratio of less than 1. 
In all of the research conducted concerning the relationship between time and 
concentrations of 8.-9-THC and its metabolites, the conclusions are consistent in that 
accurate time predictions can be accomplished and the best analytes to use for prediction 
oftime use is 8.-9-THC and either 11-0H-THC or THC-COOH. Successful predictions 
oftime have been accomplished by Huestis (1992) and Manno (2001) using 
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mathematical models relating the concentrations of the parent drug and its metabolites. 
Estimated time of marijuana use has also been accomplished by simply using the ratio of 
parent drug to metabolite concentrations. Useful means which predict elapsed time since 
marijuana ingestion occurred need to be fully developed and so that these methods can be 
used to give a better indication of impairment of an individual involved in legal cases. 
Removal of the Glucuronide Bond 
Research in the past has also been conducted to determine more effective methods 
of identifying and quantitating ~-9-THC and its metabolites in urine. With increasing 
marijuana use throughout the nation, analytical techniques that detect ~-9-THC and its 
metabolites need to be optimized (Kemp, 1995). Methods and procedures are needed that 
focus on the effectiveness of identifying the drug and its m~tabolites, and the time it takes 
to do so. 
Since ~-9-THC is readily converted by the body to its major metabolites, analysis 
of urine and plasma samples for these metabolites and ~-9-THC is often performed. 
Preparation of samples before extraction includes a step in which the glucuronide bond is 
hydrolyzed so that the conjugated metabolites can be detected. Research has been 
conducted on different ways of breaking this bond so that the maximum recovery of the 
conjugated metabolites can be obtained. 
Typically, either p-glucuronidase or alkaline conditions are used for the purpose 
of cleaving the bond between the ~-9-THC metabolites and the glucuronic acid. P-
glucuronidase can be obtained from seven species including bacteria, mollusk, bovine 
and limpet. The source from which the enzyme is obtained is dependent on what pH is 
used during the hydrolysis process (Kemp et al. , 1995). p-glucuronidase, however, is 
usuaJiy obtained from either Escherichia coli (bacteria, optimal at pH 6.8) or Helix 
pomatia (mollusk, optimal at pH 5.0). 
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Two studies (Kemp et al. 1995) conducted simultaneously focused on improving 
the method for hydrolysis. The studies focused on which of three possible methods of 
hydrolysis of the glucuronide bond would give the best recovery when extracting ~-9-
THC, 11-0H-THC, and THC-COOH from urine. Once the best reagent for hydrolysis 
had been determined, the concentration of the enzyme and the incubation period was also 
optimized to yield the best recovery of ~-9-THC and its metabolites in urine and plasma. 
Eight occasional marijuana users, who were physically and mentally in good 
health, were selected to be subjects in these studies. Four of the individuals were male 
and four were females . Each subject was given a urine drug test prior to the start of each 
session to ensure no illicit drugs were present. Breath alcohol test were administered to 
each participant and female subjects were given pregnancy test. 
Marijuana cigarettes containing 3.58% ~-9-THC were obtained from Research 
Triangle Institute; each volunteer smoked one of these cigarettes. The pace at which the 
subjects smoked was controlled by a computer. Inhalation, holding and exhalation were 
all standardized. A total of eight inhalations from the marijuana cigarette were conducted 
by each of the volunteers. 
The collection of urine from the individuals began 5 minutes after the first 
inhalation from the cigarette and was collected once an hour for 8 hours following the 
cessation of the smoking process. Samples were stored in a frozen until analysis. Urine 
collected from a male subject one hour after smoking was used for comparison of the 
three hydrolysis methods. Four, 1 mL aliquots were obtained from this stored urine for 
analysis and placed in glass culture tubes. 
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Enzymatic hydrolysis of the glucuronide bond was completed using P-
glucuronidase from E. coli and Helix pomatia. For the urine samples hydrolyzed using 
enzymes, 30 ng/mL of deuterated internal standards for the ~-9-THC, 11-0H-THC and 
THC-COOH were added to both ofthe 1 mL aliquots of urine. The urine samples were 
brought to the correct pH for the enzyme (pH 6.8 or pH 5.0) and 1mL of 0.1 M phosphate 
buffer was added to the p-glucuronidase from both sources so that optimal conditions for 
enzyme function would be obtained. 5000 Fishman units ofthe bacterial p-glucuronidase 
was added to the urine sample with a pH of 6.8 and 5000 Fishman units of the P-
glucuronidase from Helix pomatia were added to the urine sainple with a pH of 5.0. The 
tubes were capped and placed in a water bath at 3 7° for incubation overnight. 
Alkaline hydrolysis of the glucuronide bond was completed using NaOH. A 
sample of urine was again spiked with 30 ng/mL of deuterated internal standards of ~-9-
THC, 11-0H-THC and THC-COOH. The urine was brought to a pH of 13.0 with NaOH 
and placed in a 60° C water bath for 15 minutes. After incubation, the urine sample was 
removed from the water bath and allowed to cool to room temperature. 
The researchers performing this experiment also included a control in which no 
hydrolysis procedure would be used for one urine sample. The sample was spiked with 
the same concentrations of deuterated internal standards as the samples that underwent 
hydrolysis. 1 mL phosphate buffer was added to the control urine sample so that all four 
samples would have an equal volume of liquid. 
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For the purpose of extraction of the analytes from all of the urine samples, a basic 
extraction was performed first by increasing the pH of the samples to 13.0 and then using 
a mixture ofhexane and ethyl acetate to extract the ~-9-THC and 11-0H-THC. This 
solvent portion of the matrix was removed and dried completely. The THC-COOH was 
extracted from the samples by making the remaining sample acidic, then adding a 
mixture of hexane and ethyl acetate to extract the THC-COOH. The solvent was again 
removed and dried completely. Each sample was derivatized using N,o-Bis 
(Trimethylsilyl) trifluoroacetamide (BSTFA) and analyzed via GC/MS. 
After extraction and analysis, the 13-glucuronidase from E. coli was determined 
to be the best option for hydrolysis with the enzyme from Helix pomatia a far second 
best. For the control sample, concentrations of ~-9-THC and 11-0H-THC were very 
low. This indicated that no unconjugated ~-9-THC or 11-0H-THC was present in the 
urine 1 hour after smoking. The concentration of THC-COOH, however, was found to be 
1. 7 ng/mL. This shows that the initial step in the extraction process when the base is 
added is enough to cleave the THC-COOH from the glucuronide bond, even without 
incubation. 
The urine sample treated with NaOH showed similar recovery concentrations to 
that of the control. Neither the ~-9-THC nor 11-0H-THC concentrations increased by 
using alkaline conditions as the form of hydrolysis of the glucuronide bond. Also, the 
THC-COOH concentration was not significantly affected by the basic hydrolysis. The 
data gathered from this experiment showed that using base as the mean of hydrolysis will 
not yield the expected concentrations of ~-9-THC or 11-0H-THC, and the same THC-
COOH concentration can be obtained by performing no hydrolysis at all. 
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The use of p-glucuronidase for hydrolyzing the glucuronide bond of the analytes 
of interest in urine proved to be the method of choice. p-glucuronidase from E. coli 
yielded much higher concentrations of ~-9-THC and 11-0H-THC than any other 
hydrolysis method including the p-glucuronidase from Helix pomatia. Even by doubling 
the concentration of the P-glucuronidase from Helix pomatia to 10,000 units, the 
recovery of the 11-0H-THC was still lower that using the original 5000 units of P-
glucuronidase from E. coli. In the initial experiment, however, the highest concentration 
of THC-COOH was quantitated using 5000 units of p-glucuronidase from Helix pomatia. 
The use of the mollusk enzyme provided the highest yield of THC-COOH out of all the 
reagents used for hydrolysis. Further experiments using both sources of P-glucuronidase 
showed that the enzymes both produced high recoveries ofTHC-COOH. Overall, the 
most efficient reagent for the hydrolysis of the glucuronide bond for ~-9-THC, 11-0H-
THC, and THC-COOH proved to be the P-glucuronidase from E. coli. 
Now that the investigators had determined the best reagent for the removal of the 
glucuronide bond from ~-9-THC and its two main metabolites, the determination of what 
concentration of the bacterial P-glucuronidase should be used and the selection of an 
ideal incubation time for the reagent in biological specimen was completed. 
Researchers used urine from a subject who had smoked one, 3.58% ~-9-THC 
marijuana cigarette 1 hour prior to urine collection. The urine was divided into 1 mL 
samples and placed in glass culture tubes and stored in a freezer. 
Kemp et al. (1995) proceeded to optimize the concentration of the P-
glucuronidase used for hydrolysis by using three concentrations of the enzyme to 
hydrolyze 1 mL urine samples. Concentrations of 1500, 5000, and 10,000 Fishman units 
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of the ~-glucuronidase were compared. Incubation times for the enzyme in urine samples 
were also studied so that an optimal time could be selected. 0.25, 1.5, 4.0, and 16.0 hours 
were all tested to determine which of the times would allow for the best recovery of the 
analytes. 
For the purposes of this experiment, 11 -0H-THC was the only analyte quantitated 
and its concentrations used for the determination of the optimal concentration of the 
enzyme and for the incubation period. Using the same extraction method as the first 
experiment described, it was determined that the concentration of 5000 Fishman units 
and an incubation time of 16 hours (overnight) was the best conditions for the process 
when considering not only effectiveness, but price and convenience. While 10,000 
Fishman units did yield a slightly higher recovery, 5000 Fishman units and not 10,000 
units was selected as the best concentration due to cost efficiency. 16 hours was selected 
because it yielded the best recovery of 11-0H-THC and was found to be the most 
convenient time period for the individuals performing the analysis. 
~-glucuronidase from the E. coli bacteria shows to be the best option for the 
removal of the glucuronide conjugate. The enzyme produced the best recovery of 11-9-
THC and its two major metabolites when compared to two other popular methods of 
hydrolysis. The method of use of bacterial ~-glucuronidase for the purpose of hydrolysis 
was also optimized and produced high recovery of the 11-9-THC and the conjugated 
metabolites. 
The proposed research will focus on making the quantitation of 11-9-THC in urine 
more time and cost efficient. Adding a strong solution ofNaOH to the urine samples will 
not only break the glucuronide bond, but will also make the urine basic so that no pH 
adjustment will be necessary for extraction. The samples will then be incubated for a 
longer period oftime than normally used so that maximum recovery of conjugated and 
free ~-9-THC can be extracted from the samples. 
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A comparison of the proposed method for extraction and a more traditional 
method of extraction will be completed. Typically, p-glucuronidase from E. coli is used 
to hydrolyze the glucuronide bond and the extraction for ~-9-THC is completed under 
acidic conditions. By comparing the recovery, linearity, and limit of detection of the two 
methods, a determination of the usefulness of the proposed research can be made. 
CHAPTER III 
MATERIALS AND METHODS 
Procedure 
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Once 50 urine samples from donors were collected, each sample was divided into 
three, 4 mL aliquots and treated with NaOH for an alkaline extraction at pH 11.0. The 
samples were also treated with ~-glucuronidase and then extracted at an acidic pH of 6.5 
and at an alkaline pH of 11.0. 
Preparation of Sodium Hydroxide Solution 
A 10 M solution of sodium hydroxide (NaOH) was added to each test tube 
containing urine to break the glucuronide bonds. 500 mL of the 10M NaOH solution 
was made by the following steps: 
1. 40 g ofNaOH (Fisher Scientific, Houston, TX) was accurately weighed out and 
placed into a 1 00 mL Erlenmeyer flask. 
2. Type I water (Millipore, Billierica, MA) was added to the flask until a volume of 
100 mL was reached. 
3. A stirring bar was added to the flask and the flask placed on the magnetic hot 
plate until all of the NaOH had dissolved. 
Buffer Preparation 
The buffer solution used was a 1.0 M, pH 6.5 sodium phosphate buffer. This 
buffer was made by using monobasic sodium phosphate salt (NaH2P04 ) and dibasic 
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sodium phosphate salt (Na2HP04 ) dissolved in Type III water. To make this buffer, the 
following steps were completed: 
1. 69.00 grams of monobasic sodium phosphate salt (NaH2P04 ) (Fisher Scientific, 
Houston, TX) was accurately weighed out, placed in a 500 mL Erlenmeyer flask, 
and brought to a volume of 500 mL with Type III water (Millipore, Billierica, 
MA) to give a 1.0 M buffer solution with a pH of 4.5. The pH will be verified 
with an Accumet 25XL pH meter (Fisher Scientific, Houston, TX). 
2. 134.04 grams of dibasic sodium phosphate salt (Na2HP04 ) was accurately 
weighed out, placed in a 500 mL Erlenmeyer flask, and brought to a volume of 
500 mL with Type III water to give a 1.0 M buffer solution with a pH of9.5. The 
pH will be verified with an Accumet 25XL pH meter ·(Fisher Scientific, Houston, 
TX). 
3. A one liter beaker was then obtained and 500 mL of dibasic buffer added; 
measured increments of the monobasic buffer were added to the dibasic buffer 
with a 10 mL volumetric pipette. A stirring bar was then added and the beaker 
placed on to a magnetic hot plate to ensure continuous mixing of the two buffers. 
The pH was measured throughout the addition of the monobasic buffer until the 
desired pH of 6.5 is achieved. The flask of buffer solution was then covered with 
Parafilm and stored at 4 ° C for later use. 
Making of~-9-THC Standards 
In order to create a calibration curve so that ~-9-THC in the urine samples can be 
quantitated, direct standards will be made. This was completed through the following 
process: 
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1. A standard with a concentration of lmg/mL (Cerilliant, Round Rock, TX) was 
obtained and diluted with 9 mL of methanol for a final concentration of 0.1 
mg/mL. 
2. 1 mL of this solution was placed into a new, clean test tube and add 9 mL of 
methanol added for a solution equal to 10 ~-tg/mL. 
3. 1 mL of this solution was placed in another new, clean test tube and add 9 mL of 
methanol. This will gave a concentration of 1 ~-tg/mL. 
4. A 100 ~-tg/mL standard of 6-9-THC-D3 was purchased from Cerilliant (Round 
Rock, TX) and diluted to 10 ~-tg/mL with 9 mL of methanol. 1 mL of the 10 
~-tg/mL solution was diluted with 9 mL of methanol for a final concentration of 1 
~-tg/mL. 40 J.!L of this 1 J.Lg/mL 6-9-THC-D3 was used as the internal standard 
for all standards and samples so that each was equivalent to 10 ng/mL. 
5. Direct standards were created by adding 10, 20, and 80 J.!L of the 1 J.Lg/mL 
standard to separate test tubes. 40 J.!L of 1 J.Lg/mL 6-9-THC-03 was also be 
added to each tube. These standards corresponded to 6-9-THC concentrations of 
2.5, 5.0, and 20 ng/mL. 
6. The standards were dried completely in a Rapidvap (Thermo-Fisher, Houston, 
TX) then reconstituted using 50J,!L of Bis(Trimethylsilyl)-trifluoroacetamide 
(BSTF A). The samples were capped and incubated at 60°C for 30 minutes to 
derivatize the 6 -9-THC and the 6-9-THC-D3 internal standard. 
Alkaline Extraction oftl-9-THC in the Urine Samples Using NaOH 
Once the tl-9-THC standards were prepared, the alkaline extraction of the urine 
samples was started. This was accomplished through the following steps: 
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1. 100 J..tL of a 10 M NaOH solution was added to each of the 50 test tubes and was 
incubated at 37°C in a water bath for 1.5 hours. 
2. After incubation, the tubes were allowed to cool to room temperature and 9 mL 
of a Hexane:Ethyl Acetate solution (4:1) was added and capped. 
3. The tubes were placed on a platform rotator for 1.5 hours and mixed at a slow 
speed to prevent emulsion. 
4. The tubes were centrifuged at 3000 RPM for 25 minutes following the 
extraction. 
5. The Hexane:Ethyl Acetate solutions were transferred to clean 16x125 mm tubes 
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX). 
6. Once dry, the tubes were allowed to cool and then 50 J..tL ofBis(Trimethylsilyl)-
trifluoroacetamide (BSTF A) was added to each tube and the tubes capped. 
7. All the tubes were capped and then heated at 60°C for a minimum of 30 minutes 
to derivatize the tl-9-THC and internal standard. 
8. The tubes were allowed to cool to ambient temperature and then transferred to 
auto sampler vials containing 100 J..tL inserts. 
9. All vials were capped and placed on the GC/MS for injection. 
10. 2 J..tL of each sample was analyzed using a Gas Chromatograph/ Mass 
Spectrometer (Clarus 600 EI+, Perkin Elmer, Shelton, CT). 
Acid Extraction of !l-9-THC in Urine Samples using fJ-glucuronidase 
The acid extraction process will be accomplished by completing the following 
steps: 
1. 100 J.!L of ~-glucuronidase from E. coli (Thermo Fisher, Houston, TX) was 
added to all test tubes. 
2. Each sample was buffered with 1 mL of 1.0 M sodium phosphate buffer (pH 
6.5) and incubated in a 3 7 °C water bath for 60 minutes. 
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3. 9 mL of a hexane:ethyl acetate solution (4:1) was added to each sample and the 
tubes capped. 
4. The tubes were placed on a platform rotator for 1 hour and mixed at a slow 
speed to prevent emulsion. 
5. The tubes were all centrifuge at 3000 RPM for 25 minutes following the 
extraction. 
6. The hexane:ethyl acetate solutions were transferred to clean 16x 125 mm tubes 
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX). 
7. Once dry, the tubes were allowed to cool and then 50 J.!L of Bis(Trimethylsilyl)-
trifluoroacetamide (BSTF A) was added to each tube and the tube capped. 
8. All of the tubes were vortexed and then heated at 60°C for a minimum of30 
minutes to derivatize the /l-9-THC and internal standard. 
9. The tubes were allowed to cool to ambient temperature and then the solution 
transferred to autosampler vials containing 100 J.!L inserts. 
10. The vials were capped and placed on the GC/MS for injection. 
11 . 2 f.!L samples were analyzed using a Gas Chromatograph/ Mass Spectrometer 
(Clarus 600 Et, Perkin Elmer, Shelton, CT). 
Alkaline Extraction of 1'1-9-THC in Urine Samples using {3-glucuronidase 
The alkaline extraction process using P-glucuronidase will be accomplished by 
completing the following steps: 
1. 100 f.!L of P-glucuronidase from E. coli (Thermo Fisher, Houston, TX) was 
added to all test tubes. 
2. Each sample was buffered with 1 mL of 1.0 M sodium phosphate buffer (pH 
6.5) and incubated in a 37 °C water bath for 60 minutes. 
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3. 100 f.!L of 1.0 M NaOH was added to each of the test tubes in order to make the 
urine samples alkaline. 
4 . 9 mL of a Hexane:Ethyl Acetate solution ( 4:1) was then added to each sample 
and the tubes capped. 
5. The test tubes were placed on a platform rotator for 1 hour and mix at a slow 
speed to prevent emulsion. 
6. The tubes were then centrifuge at 3000 RPM for 25 minutes following the 
extraction. 
7. The hexane:ethyl acetate solutions were transferred to clean 16x125 mm tubes 
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX). 
8. Once dry, the tubes were allowed to cool and then 50 f.!L ofBis(Trimethylsilyl)-
trifluoroacetamide (BSTFA) was added to each tube and the tube capped. 
9. All tubes were vortexed and then heated at 60°C for a minimum of30 minutes 
to derivatize the 1'1-9-THC and internal standard. 
10. The tubes were allowed to cool to ambient temperature and then transferred to 
autosampler vials containing 1 00 )lL inserts. 
11. All vials were capped and place on the GC/MS for injection. 
12. 2 )lL of all samples was analyzed using a Gas Chromatograph/ Mass 
Spectrometer (Clarus 600 Et, Perkin Elmer, Shelton, CT). 
GC/MS method parameters for both extraction processes were as follows: 
Duration: 14.0 minutes 
Solvent Delay Start 1: 0.0 minutes 
Solvent Delay End 1: 12.6 minutes 
Solvent Delay Start 2: 14.2 minutes 
Solvent Delay End 2: 16.0 minutes 
Number of Functions: 1 
Function 1: SIR of 5 masses 
Time: 12.70 to 14.10 minutes 
Ion Mode: Er+ 
Inter Channel Delay: 0.01 seconds 
Channel Mass(Da) Dwell(s) 
371,386, 387 0.05 
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2 389,390 0.05 
Instrument Control Method 
Instrument Name: Clarus MS I 
Instrument Type: PE AutoSystem GC with built-in Autosampler 
Channel Parameters 
Solvent Delay Time: 0.00 minutes 
Run Time: 16.00 minutes 
Autosampler Method 
Syringe Capacity: 5.0 ~L 
Injection Speed: Normal 
Viscosity Delay: 0 
Pre-Injection Solvent Washes: 2 
Post-Injection Solvent Washes: 10 
Injection Volume: 2 ~L 
Sample Pumps: 3 
Wash/Waste Vial Set: 1 
Pre-injection Sample Washes: 0 
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Carriers Parameters 
Carrier Control: PFlow-H2 
Column Length: 30.00 meters 
Diameter: 250 J.lm 
Vacuum Compensation: On 
Split Flow: 25.0 mL/minute 
Flow Rate: 0.50 mL/minute 
Initial Hold: 999.0 minutes 
Valve Configurations and Settings 
Valve 1: Split On 
Heated Zones 
Injector A: CAP 
Setpoint: 250 °C 
Transferline: 270 oc 




Initial Temperature: 80 oc 
Maximum Temperature: 300 °C 
Initial Hold: 2.00 minutes 
Equilibration Time: 0.2 minutes 
Ramp: 15 °C/ minute to 280 oc, hold for 0.67 minutes 
Timed Events 
Split 1 set to 0 at -0.30 minutes 
Split 1 set to 50 at 3.00 minutes 
• 
CHAPTER IV 
DATA AND RESULTS 
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Urine samples from anonymous donors who use marijuana were collected and 
used for the purpose of this research. Collection cups in brown paper bags with informed 
consent forms and urine classification forms were issued to a third party individual who 
distributed the bags to anonymous participants who were known marijuana users. The 
filled cups and classification forms were returned by the third party individual to the 
laboratory and stored locked until the research process began. All collection methods and 
procedures were approved by the Internal Review Board (IRB) of the University of 
Southern Mississippi. The IRB form, informed consent form, and urine classification 
form can be found in Appendixes A, B, and C. 
A total offifty (50) samples were collected from three classifications of marijuana 
users. Each participant recorded the number of times they use marijuana per week, the 
time period it had been since they last smoked marijuana, and the method by which they 
ingested marijuana. Of the samples collected, 39 participants recorded that they were 
heavy smokers, 8 said that they were light smokers and 3 considered themselves medium 
smokers. Thirty three people smoked marijuana cigarettes, 16 participants used a pipe, 
and 1 donor smoked marijuana by blunt. The time frame since participants last smoked 
ranged from 20 minutes to 4 hours. The urine sample classification form also contained a 
blank for the participants to indicate if they were ingesting marijuana at the time they 
donated the urine sample. None of the users indicated that they were using marijuana 
while they were collecting urine so this category was omitted from the sample description 




Sample No. Marijuana Use Time Frame Method of Ingestion 
0001 Heavy 30 minutes Pipe 
0002 Heavy 1.5 hours Pipe 
0003 Heavy 1 hour Blunt 
0004 Heavy 2.5 hours Pipe 
0005 Heavy 3.5 hours Pipe 
0006 Heavy 1.5 hours Pipe 
0007 Heavy 3.5 hours Pipe 
0008 Light 5 hours Pipe 
0009 Medium 3 hours Pipe 
0010 Heavy 45 minutes Pipe 
0011 Heavy 2 hours Pipe 
0012 Light 20 minutes Pipe 
0013 Heavy 1 hour Pipe 
0014 Heavy 2.5 hours Pipe 
0015 Light 2 hours Pipe 
0016 Heavy 45 minutes Pipe 
0017 Heavy 45 minutes Pipe 
0018 Heavy 30 minutes Marijuana Cigarette 
0019 Heavy 1 hour Marijuana Cigarette 
0020 Heavy 1.5 hours Marijuana Cigarette 
0021 Heavy 30 minutes Marijuana Cigarette 
0022 Light 1 hour Marijuana Cigarette 
0023 Heavy 2 hours Marijuana Cigarette 
0024 Heavy 2.5 hours Marijuana Cigarette 
0025 Heavy 1 hour Marijuana Cigarette 
Table 1, cont. 
Sample Descriptions (cont.) 
Sample No. Marijuana Use Time Frame Method of Ingestion 
0026 Heavy 30 minutes Marijuana Cigarette 
0027 Light 45 minutes Marijuana Cigarette 
0028 Heavy 1 hour Marijuana Cigarette 
0029 Heavy 2.5 hours Marijuana Cigarette 
0030 Medium 2 hours Marijuana Cigarette 
0031 Heavy 3 hours Marijuana Cigarette 
0032 Heavy 1.5 hours Marijuana Cigarette 
0033 Heavy 30 minutes Marijuana Cigarette 
0034 Heavy 45 minutes Marijuana Cigarette 
0035 Heavy 1 hour Marijuana Cigarette 
0036 Heavy 2.5 hours Marijuana Cigarette 
0037 Light 1.5 hours Marijuana Cigarette 
0038 Heavy 30 minutes Marijuana Cigarette 
0039 Light 2.5 hours Marijuana Cigarette 
0040 Heavy 4 hours Marijuana Cigarette 
0041 Heavy 3.5 hours Marijuana Cigarette 
0042 Heavy 2 hours Marijuana Cigarette 
0043 Heavy 45 minutes Marijuana Cigarette 
0044 Medium 30 minutes Marijuana Cigarette 
0045 Heavy 30 minutes Marijuana Cigarette 
0046 Heavy 2 hours Marijuana Cigarette 
0047 Heavy 1.5 hours Marijuana Cigarette 
0048 Light 3 hours Marijuana Cigarette 
0049 Heavy 2.5 hours Marijuana Cigarette 
0050 Heav~ 1 hour Marijuana Cigarette 
Table 1: Description of the samples obtained from participants who use marijuana. 
Heavy denotes those participants who use marijuana everyday, medium is 
representative of participants who use marijuana 1-3 times a week, and light is 
indicative of those participants who use marijuana 1 time a month or recreationally. 
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The first extraction performed on the urine samples was the acidic extraction at 
6.5 using ~-glucuronidase. Four mL of each urine sample was placed into a test tube and 
spiked with 6-9-THC-03 internal standard to give a concentration of 10 ng/mL. One mL 
of 1.0 M sodium phosphate buffer was added to each of the 50 samples to buffer the urine 
to create an optimum pH environment for ~-glucuroidase. The samples were then treated 
with 100 flL of the ~-glucuronidase from E. coli. before being placed in a 3rC water 
bath for 1.5 hours. The urine samples were removed from the water bath and extracted 
with Hexane:Ethyl Acetate ( 4:1) for 1.5 hours on a platform rotator. The extraction 
solvent was removed and dried completely before being reconstituted and derivatized for 
30 minutes at 65° C with Bis(trimethylsilyl)trifluoro acetamide (BSTF A) + 1% 
trimethylsilyl (TMS). The samples were analyzed via GC/MS using selective ion 
monitoring and quantitated using the 386 and 389 ion fragments. 
The 389 internal standard ion fragment's area and height were measured by peak 
integration. The mean, standard deviation, and estimated standard error for the 389 area 
and height were calculated so that they could be later used to determine the efficiency of 
the acidic extraction versus the initial basic extraction (See Table 2). 
43 
Table 2 
/)-glucuronidase 389 Ion Area and Height 
~-Giu. 389 389 
Sample No. ion area ion height 
0001 14393 794973 
0002 17095 901509 
0003 10294 518276 
0004 19149 1002041 
0005 18904 1043677 
0006 9412 504615 
0007 15942 790738 
0008 24563 1293703 
0009 18585 1011591 
0010 6795 371533 
0011 12441 665313 
0012 15765 803598 
0013 15756 791133 
0014 17673 897652 
0015 7798 444485 
0016 11959 627988 
0017 10596 529645 
0018 18938 958914 
0019 13394 694693 
0020 12930 703919 
0021 7405 382989 
0022 12050 690510 
0023 12622 674762 
0024 10832 288179 
0025 16032 832375 
Table 2, cont. 
/3-glucuronidase 389 Ion Area and Height (cont.) 
P-Giu. 389 389 
Sample No. ion area ion height 
0026 8176 414499 
0027 13974 756934 
0028 10196 561887 
0029 8618 473625 
0030 7339 393727 
0031 8227 435176 
0032 4858 267655 
0033 3426 192830 
0034 4072 227105 
0035 6227 345139 
0036 9778 498037 
0037 7057 404100 
0038 7981 433329 
0039 7694 424618 
0040 9187 515476 
0041 5977 329192 
0042 10161 569095 
0043 8794 488852 
0044 3998 217594 
0045 6636 343875 
0046 9098 514134 
0047 6164 348817 
0048 10337 539342 
0049 5381 254160 
0050 6576 352187 
Mean 10620.47059 Mean 559227.1569 
Standard 
Standard Dev. 4929.657 Dev. 259735.274 
Est. Std. 
Est. Std. Error 497.945 Error 26235.886 
Table 2: Calculations for ~-glucuronidase area and height of the 389 ion 
fragment from .::1-9-THC-D3 internal standard used to establish any significant 
difference between the extractions at pH 6.5 and pH 11. 
Mean = :EX/N 
Sandard Dev. = ~[(:EX2/N)-Mean2] Est. Std. Error= SD/~(N~ -1 + N2-l) 
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An alkaline extraction of another 4 mL of the same 50 urine samples was 
performed by using a strong solution ofNaOH to break the glucuronide bond. As with 
the acidic extraction, 4 mL of each of the 50 samples was placed into clean test tubes and 
~-9-THC-D3 internal standard added to give a final concentration of 10 ng/mL. Ten 
molar NaOH (100!-!L) was added to each of the 50 samples before they were placed into a 
3rc water bath for 1.5 hours. The test tubes were removed from the water bath and 9 
mL ofHexane:Ethyl Acetate (4:1) was added to each sample and extracted for 1.5 hours 
by mixing on a platform rotator. When finished, the samples were centrifuged and the 
extraction solvent removed, dried completely, reconstituted with BSTFA and incubated 
for 30 minutes at 65° C to derivatize the ~-9-THC and the internal standard. 
The samples were then analyzed via GC/MS and the 389 ion fragment's area and 
height measured. The basic extraction using NaOH did not yield any ~-9-THC so the 
compound's 386 ion fragment could not be used for comparison of efficiency. The 389 
ion fragment was used to determine the effectiveness of the two different pH extractions. 
The mean, standard deviation, and estimated standard error of the 389 ion's area and 
height were each calculated for statistical comparison with the acidic extraction (See 
Table 3). (The 386 ion fragment from ~-9-THC was not used to compare the two 
techniques to determine efficiency due to the absence of the ion fragment when the 
NaOH was used to cleave the glucuronide bond. However, the 386 ion's area and height 
from the acidic 13-glucuronidase extraction were both measured and recorded for 
statistical comparison to an altered basic extraction described later on.) 
The mean values for both area and height of the 389 ion for the basic NaOH 
extraction were higher than those from the acidic 13-glucuronidase extraction. The 
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standard deviation for the area and height of the ion fragment for the basic extraction was 
also less than that of the acidic extraction; therefore, the estimated standard error was less 
for the basic extraction using NaOH. Overall, the results for the un-conjugated 389 
internal standard ion fragment were more consistent with the basic extraction than the 
acidic extraction. 
A statistical comparison of the acidic and basic extraction techniques was 
completed using the previous calculated 389 ion values from Tables 2 and 3. To 
determine if the two extractions were statistically different, a two-tail t test was 
performed at the .05 level of significance. The estimated standard error of difference for 
both the area and the height for the two extractions was calculated. Then, using the 
means from each, at ratio was determined. This ratio was then compared to a t value 
table for a degree of freedom of 120. The t ratio calculated for the two extractions 
exceeded the value from the table which meant the two extractions were significantly 
different (See Table 4). 
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Table 3 
NaOH 389 Ion Area and Height 
NaOH 389 389 
Sample No. ion area ion height 
0001 9021 500695 
0002 5421 309502 
0003 12824 707619 
0004 12632 675017 
0005 12802 693488 
0006 9677 535401 
0007 1463 1 771324 
0008 13201 720978 
0009 12573 682823 
0010 9497 535645 
0011 9162 499413 
0012 8754 486746 
0013 13241 735737 
0014 13405 722440 
0015 13356 720024 
0016 13499 707704 
0017 11536 629958 
0018 14058 744113 
0019 4930 267893 
0020 13634 743073 
0021 9953 545529 
0022 11 869 651397 
0023 10771 577819 
0024 11656 643128 
0025 14043 788542 
Table 3, cont. 
NaOH 389 Jon Area and Height (cont.) 
NaOH 389 389 
Sample No. ion area ion height 
0026 17927 993447 
0027 13006 736469 
0028 13450 765675 
0029 13107 711763 
0030 11617 651384 
0031 12719 701910 
0032 12933 720757 
0033 12807 694880 
0034 6601 381825 
0035 13238 736987 
0036 10438 582140 
0037 11572 633464 
0038 12196 639679 
0039 10652 597070 
0040 11156 599751 
0041 10244 597782 
0042 5489 296208 
0043 10072 563709 
0044 10901 603179 
0045 12347 680824 
0046 9267 519659 
0047 9562 534332 
0048 8946 502247 
0049 11105 594259 
0050 10987 600786 
Mean 11154.39216 Mean 612482.0196 
Standard Dev. 2893.109 Standard Dev. 158058.679 
Est. Std. Error 292.233 Est. Std. Error 15965.523 
Table 3: Calculations for NaOH area and height of the 389 ion fragment from 
~-9-THC-03 internal standard used to establish any significant difference between 
the extractions at pH 6.5 and pH 11. 
Mean = LX!N 
Sandard Dev. = .V[(LX2/N)-Mean2] Est. Std. Error = SD/.V(N1 -1 + N2-1) 
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Table 4 
Statistical Comparison off>-glucuronidase and NaOH Ion 
Mean 
fl-glu 389 Height 570404 
NaOH 389 Height 624724 
fl-glu 389 Area 
















Table 4: Statistical comparison of the two methods for breaking the glucuronide 
bond. Using the 389 ion fragment's average height and area, for the acidic and basic 
extractions, the two methods proved to be signigficantly different. The t value for 
the .05 level of significance for a degree of freedom of 120 is 1.98. Both of these 
calculated values fall outside this level and are therefore significantly different. 
Est. Std. Error of Difference = --f(SE1
2 + SE22) 
tratio = (Mean1-Mean2)/SED 
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In order to do a comparison of extraction efficiencies for ~-9-THC for an acidic 
and a basic extraction, another set of 50 samples had to be extracted using ~­
glucuronidase to cleave the glucuronide bond and then using 10 M NaOH to bring the 
urine back to a basic pH before extraction. 
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Like in the other two procedures, 4 mL of each of the samples was placed into a 
test tube and spiked with ~-9-THC-D3 internal standard at 10 ng/mL. This set of 
samples was first treated with ~-glucuronidase and placed in a water bath at 37°C for 1.5 
hours. When the samples were removed from the water bath, 100 J!L of 10M NaOH was 
added to each test tube and vortexed before extraction with Hexane: Ethyl Acetate ( 4:1) 
for 1.5 hours. The extraction solvent was removed, dried down, reconstituted using 
BSTF A, and then incubated for 30 minutes at 65° to ensure derivatization of both the ~-
9-THC and the ~-9-THC-D3. These 50 samples were analyzed via GC/MS and statistics 
calculated for the 386 and 389 ion fragments' areas and heights (See Tables 5 and 6). 
Since data concerning the 386 ion fragment from an acidic and basic extraction 
had now been obtained, these values could be statistically compared to determine if there 
was a significant difference in the two ~-glucuronidase extractions for ~-9-THC. 
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Table 5 
f)-glucuronidase Acidic 386 and 389 Jon Areas and Heights 
P-Giu. 
Acidic 386 386 389 389 
Sample No. ion area ion height ion area ion height 
0001 3814 207493 14393 794973 
0002 2142 123954 17095 901509 
0003 15964 773392 10294 518276 
0004 4346 107852 19149 1002041 
0005 730 44443 18904 1043677 
0006 582 32772 9412 504615 
0007 795 44558 15942 790738 
0008 0 0 24563 1293703 
0009 386 21657 18585 1011591 
0010 3432 186884 6795 371533 
0011 814 43477 12441 665313 
0012 0 0 15765 803598 
0013 14729 804213 15756 791133 
0014 930 37502 17673 897652 
0015 0 0 7798 444485 
0016 19334 1041438 11959 627988 
0017 8870 502056 10596 529645 
0018 2025 55210 18938 958914 
0019 2026 109181 13394 694693 
0020 1587 84204 12930 703919 
0021 2184 99470 7405 382989 
0022 691 43706 12050 690510 
0023 549 35820 12622 674762 
0024 1442 77540 10832 288179 
0025 24835 479521 16032 832375 
Table 5, cont. 
~-glucuronidase Acidic 386 and 389 Ion Areas and Heights (cont.) 
P-Giu. Acidic 386 386 389 389 
Sample No. ion area ion height ion area ion height 
0026 2593 123824 8176 414499 
0027 0 0 13974 756934 
0028 0 0 10196 561887 
0029 135 8613 8618 473625 
0030 4419 248727 7339 393727 
0031 2054 106231 8227 435176 
0032 5957 329455 4858 267655 
0033 82 5165 3426 192830 
0034 31 1833 4072 227105 
0035 0 0 6227 345139 
0036 4343 243360 9778 498037 
0037 0 0 7057 404100 
0038 2158 115533 7981 433329 
0039 0 0 7694 424618 
0040 0 0 9187 515476 
0041 0 0 5977 329192 
0042 1119 67596 10161 569095 
0043 0 0 8794 488852 
0044 1307 66627 3998 217594 
0045 213 11243 6636 343875 
0046 1566 40784 9098 514134 
0047 617 41287 6164 348817 
0048 1208 70191 10337 539342 
0049 249 14048 5381 254160 
0050 2550 70163 6576 352187 
Mean 2807.72549 127870.7647 10620.47059 559227.1569 
Standard Dev. 5126.102 220216.890 4929.657 259735.274 
Est. Std. Error 517.788 22244.130 497.945 26235.886 
Table 5: Shows the areas and heights for the 386 and 389 ion fragments for the 
acidic 13-glucuronidase extractions. Statistics were calculated for these values so 
that they could be compared to the values obtained from use of 13-glucuronidase 
at a basic pH. 
Mean = LXIN 




P-glucuronidase Basic 386 and 389 Ion Areas and Heights 
P-Giu. Basic 386 386 389 389 
Sample No. ion area ion height ion area ion height 
0001 1922 110958 8905 486048 
0002 980 57389 111 11 598290 
0003 17091 879164 10983 558492 
0004 576 37884 10542 594063 
0005 216 14222 9005 513497 
0006 456 29245 9267 481836 
0007 446 28103 10388 564070 
0008 0 0 11324 610844 
0009 122 6674 10237 550501 
0010 4135 227534 7620 402485 
0011 411 24930 9664 524213 
0012 0 0 10413 547668 
0013 11192 564074 11776 623748 
0014 124 8121 9551 540159 
0015 0 0 9079 516598 
0016 16691 919941 9932 505326 
0017 8624 466782 10216 530720 
0018 979 25946 11239 617426 
0019 1578 89029 11368 603157 
0020 1222 69156 11469 612272 
0021 1806 96186 9074 486637 
0022 414 24541 10837 575996 
0023 412 27367 11 117 614232 
0024 265 13599 7961 423583 
0025 19845 410506 14001 763267 
Table 6, cont. 
P-glucuronidase Basic 386 and 389 Ion Areas and Heights (cont.) 
P-Giu. Basic 386 386 389 389 
Sample No. ion area ion height ion area ion height 
0026 2275 121766 10642 543617 
0027 0 0 10640 574128 
0028 0 0 10431 594381 
0029 153 9702 12378 653794 
0030 4013 232969 20166 1157706 
0031 623 38518 4208 226967 
0032 10448 577149 11705 630015 
0033 250 15947 10501 555532 
0034 64 4271 10226 574329 
0035 0 0 9833 531385 
0036 2713 156975 8553 470859 
0037 85 5762 9962 538359 
0038 2316 127540 11026 587095 
0039 0 0 9991 562471 
0040 0 0 8973 502693 
0041 0 0 10646 593721 
0042 969 56657 12764 676718 
0043 14 850 111 78 621692 
0044 2607 138675 12394 641159 
0045 146 8731 12848 671544 
0046 6708 174948 10300 547208 
0047 968 57620 10254 542911 
0048 778 47532 10177 542692 
0049 140 7752 10368 539362 
0050 8221 167351 11146 574344 
Mean 2615.372549 119263.7647 10368.19608 558827.4314 
Standard Dev. 4716.679 210983.887 2479.094 140068.840 
Est. Std. Error 476.432 21311.504 250.413 14148.368 
Table 6: Shows the areas and heights for the 386 and 389 ion fragments for the 
basic J3-glucuronidase extractions. Statistics were calculated for these values so 
that they could be compared to the values obtained from use of J3-glucuronidase at 
an acidic pH. 
Mean= :EX/N 
Sandard Dev. = " [(:EX2/N)-Mean2] Est. Std. Error = SD/"(N1-1 + N2-1) 
54 
55 
To determine if the two methods for extraction of L\-9-THC were significantly 
different or not, at test was completed (See Table 7) using the 386 ion fragment data 
from Table 5 and Table 6. First, the heights of the 386 ion from the acidic and basic 
extractions were compared and at ratio calculated. This value was compared to a t table 
for a .05 level of significance. The t ratio for the heights for the two extractions for the 
386 ion was determined to not be significantly different. The value for the t ratio fell 
well below the accepted value for a degree of freedom of 120. 
The data from the areas for the 386 ion fragment for the basic and acidic 
extractions was also statistically compared using a two tail t test. Again, at a .05 level of 
significance for degrees of freedom of 120, the acidic and basic extractions proved to not 
be significantly different. The t ratio for the two areas again. fell well below the t value 
from the table. 
Using three direct standards of L\-9-THC and its internal standard, a calibration 
curve was made so that the concentrations from the 50 urine samples for the acidic and 
the basic extractions could be determined. The L\-9-THC-D3 internal standard 
concentration of the samples was 10 ng/mL and the L\-9-THC concentrations used were 
2.5, 5.0, and 20.0 ng/mL. The curve was constructed using the 386 and 389 ion fragment 
area ratios and was linear from 0 to 20 ng/mL as seen in Figure 3. 
The concentration of L\-9-THC for each of the 50 samples for both extractions 
was determined using this calibration curve. Concentrations of L\-9-THC for both the 
acidic and basic extractions were determined so that they could be compared for 
statistical difference also. 
Table 7 
Statistical Comparison of Acidic and Basic p-glucuronidase 386 Ion 
Standard Est Stand Error of 
Acidic 386 Height 
Basic 386 Height 
Acidic 386 Area 















Table 7: Statistical comparison of the areas and heights of the 386 ion 
0.283 
0.277 
fragment from the acid and basic ~-glucuronidase extractions. The extraction 
methods following treatment with ~-glucuronidase are not significantly different. 
Using the t value for a .05 level of significance for a degree of freedom of 120, the 
calculated values proved not to be significantly different. 
Est. Std. Error of Difference = --.f(SE1
2 + SE22) 
tratio = (Mean,-Mean2)/SED 
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. 16-lVIar-2010 + 08:22:32 
Compound 2 name: THC 
Correlation coefficient: r = 0.999860, r112 = 0.999719 
Calibration cuNe: 0 .132712 *x +-0 .127612 
Response type: Internal Std (Ref 1 ), Height* (IS Cone . I IS Height) 
CuNe type: Linear, Origin: Exclude, Weighting: Null , Axis trans: None 
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Figure 3. Calibration curve made from 3 standards of ~-9-THC at values of2.5, 
5.0, and 20.0 ng/mL. It demonstrated the linearity of the standards as seen by the 
r2 value. 
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In order to further analyze the 13-glucuronidase acidic and basic extractions for 
significant difference, the concentrations of Li-9-THC from each extraction were 
statistically compared. The mean, standard deviation and standard error was calculated 
for both sets of data. Through one of the two extractions, 36 of the 50 samples yielded a 
concentration of Li-9-THC detectable by the GC/MS. 14 of the samples did not show to 
contain any Li-9-THC or the concentration was below the limit of detection. These 
samples that appeared to have 0 ng/mL Li-9-THC when extracted via acidic or basic 
conditions were excluded from data analysis in order to not skew the statistical results. 
The concentrations of Li-9-THC from both extractions can be found in Table 8. 
Again, using the two-tail t test, at ratio was calculated (See Table 9) for the 
difference in the concentrations of Li-9-THC extracted by both methods. The t ratio for 
the concentrations from the acidic and basic extractions was found to fall below the 
accepted value from the t table for a .05 level of significance at a degrees of freedom of 
120. This calculation again proved that the two extractions were equally efficient in 
extracting Li-9-THC and were not statistically different. 
After determining that the 13-glucuronidase acidic and basic extractions were not 
significantly different, the percent recovery for the two extractions was calculated. This 
was completed by using the average area and height of the 389 ion fragment because it, 
unlike the 386 ion fragment from Li-9-THC, was added to each ofthe standards and 
samples in the same concentration. Using the 5.0 ng/mL standard 's 389 ion's height and 
area as the theoretical recovery, the average percent recovery for each extraction was 
calculated using the average area and height from both extraction techniques. Table 10 
shows the average percent recovery for the 389 ion fragment based off of area and height. 
The percent recoveries for the two extractions were very close in value, but the acidic 
extraction did show a slightly better recovery than the basic extraction. 
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Another goal ofthis research was to compare the 6 -9-THC concentrations found 
in the urine samples from donors to the time frame since each person had last smoked to 
determine a peak 6-9-THC concentration versus time in an uncontrolled study. The time 
elapsed since the participant had last ingested marijuana versus the concentration of 6 -9-
THC found in their urine by both extractions was plotted so that a relationship could be 
easily seen. As compared to literature, the peak concentration of 6-9-THC in urine from 
the participants occurred approximately 1 hour earlier than it did in controlled studies 
(See Fig. 4). 
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Table 8 
p-glucuronidase Acidic and Basic Concentrations 
Sample No. p-glu. Acid Concentration P-glu. Base Concentration 
0001 2.92 2.68 
0002 1.99 1.68 
0003 12.25 12.85 
0004 0 1.44 
0005 1.28 1.17 
0006 1.45 1.42 
0007 1.39 1.34 
0009 1.12 1.05 
0010 4.72 5.22 
0011 1.46 1.32 
0012 1. 13 0 
0013 8.62 7.78 
00 14 0 1.07 
0016 13.45 14.68 
0017 8.1 7.6 
0019 2.15 2.07 
0020 1.86 1.81 
0021 2.92 2.45 
Table 8 (cont.) 
f3-glucuronidase Acidic and Basic Concentrations (cont.) 
0022 1.43 1.28 
0023 1.36 1.3 
0026 3.2 2.65 
0029 1.11 1.07 
0030 5.72 2.48 
0031 2.8 2.24 
0032 10.24 7.86 
0033 0 1.18 
0034 0 1.02 
0036 4.64 3.47 
0037 0 1.05 
0038 2.97 2.6 
0042 1.86 1.59 
0044 3.25 2.59 
0045 0 1.06 
0047 1.85 1.76 
0048 0 1.62 
0050 2.51 0 
Mean 3.08 2.94 
Standard Deviation 3.43 3.30 
Standard Error 0.42 0.40 
Table 8: Concentrations of ~-9-THC found using both the basic and acidic 
~-glucuronidase methods. The omitted samples are ones that did not show 
to contain ~-9-THC when extracted using either method. 
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Table 9 
Statistical Comparison ofConcentrations 
Standard Est Stand Error of 
Mean Error Difference 
p-glu Acid 
Cone. 3.08 0.42 
P-glu Basic 
Cone. 2.94 0.40 
0.58 
0.241 
Table 9: Statistical comparison of concentrations from the acidic and basic 
13-glucuronidase extractions. The t ratio for these concentrations fell below 
the t value for .05 level of significance for a degre of freedom of 120 and 
showed no significant difference. 
Est. Std. Error of Difference= --.f(SE1
2 + SEl ) 




Standard Acidic Extraction Basic Extraction 
Height Area Height Area Height Area 
590401 10555 570403 10825 569996 10567 
Average % Recovery 96.61% 103% 96.50% 100% 
Table 10: Summary of percent recovery of the ~-9-THC-D3 389 ion fragment. It 
shows that the acidic and basic pH extractions both prove to be effective in 
extracting ~-9-THC-D3 internal standard from urine. 
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Concentration vs Time 
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Figure 4. Plot of concentration of ~-9-THC in urine versus time elapsed after an 
individual smoked. Peak THC concentration showed to be between 30 minutes and 





While marijuana contains many different cannabinoids, one in particular, 6 -9-
Tetrahydrocannabinol (6-9-THC), is responsible for the psychoactive effect experienced 
by users of marijuana. 6 -9-THC only becomes psychoactive after the compound is 
heated. The effects experienced by users of marijuana are not consistent person to person 
and therefore make the drug hard to classify. Some of the more common effects of 
marijuana are described as euphoria, impaired memory, and increased appetite and heart 
rate (Huestis, 2006). 
At high doses, marijuana is a central nervous system depressant. Marijuana is 
usually smoked due to the quick and effective delivery ofthe 6 -9-THC to the brain, but it 
can also be orally ingested after heated. The drug acts upon a user through cannabinoid 
receptors found in the brain. When smoked, 6 -9-THC has a higher bioavailability than 
when it is ingested orally. Effects can be felt almost immediately by a user when the 
marijuana is smoked, but when orally ingested the drug takes longer to take effect. 
However, once the drug does take effect after being orally ingested, the effects last longer 
(Huestis, 2006). 
Due to its lipophillic nature, 6 -9-THC is readily metabolized by P450 enzymes in 
the body to its two major metabolites, 11-0H-THC and THC-COOH. 11-0H-THC is 
psychoactive while THC-COOH is not (Kemp, 1995). THC-COOH is the end product 
for the metabolism of 6-9-THC. The THC-COOH is slowly cleared from the blood into 
the urine because it is polar. THC-COOH also has a long half life in the body because it 
is stored in the fat and is not readily cleared from the body because it is also lipophillic. 
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The lipophillic nature of ~-9-THC and THC-COOH causes the majority of each 
compound to be conjugated to glucuronic acid in order to make it more water soluble 
before it enters the urine to be excreted from the body. This means that when the ~-9-
THC or THC-COOH is found in urine, it is attached to glucuronic acid. This glucuronide 
bond must be broken in order for the compounds to be extracted and detected via 
chromatographic methods. 
While THC-COOH can be found in a person's urine hours or days after marijuana 
ingestion, it is not psychoactive and indicates nothing about the impairment of the 
individual. When trying to determine impairment from marijuana use, the compound that 
is looked for in a person's urine is the parent drug, ~-9-THC. Since it is known that ~-9-
THC is readily metabolized once it enters the body, its pre~ence in urine is indicative of 
recent marijuana use. A high concentration of ~-9-THC in urine would indicate that the 
person used marijuana recently and is under the influence of the drug. 
With marijuana use becoming more common, quicker, efficient methods for 
determining ~-9-THC concentration and studies relating it to impairment are necessary. 
In this research, urine samples were collected from a variety of known users of marijuana 
at different times after the person ingested marijuana using various devices. The samples 
were treated with either an enzyme or strong base to break the glucuronide bond. Three 
different extraction methods were used and the results from each compared in order to 
determine efficiency of the extraction method. 
The first experiment was conducted in order to test the efficiency ofNaOH and~­
glucuronidase for cleaving the bond between the glucuronic acid and the ~-9-THC, and 
to determine if the extraction could be completed at an acidic pH and still be efficient. 
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The f3-glucuronidase method was completed at an acidic pH while the NaOH extraction 
was performed at an alkaline pH. When f3-glucuronidase was used to break the bond, and 
the extraction completed at an acidic pH, ~-9-THC was recovered in 39 of the 50 urine 
samples and could be quantitated in 29 of the samples. This method proved to be 
efficient for extracting ~-9-THC from the urine samples. When NaOH was used to break 
the glucuronide bond and to create an alkaline pH for the extraction, ~-9-THC was not 
recovered in any of the same samples. This showed that the strong solution ofNaOH did 
not work as well, if at all, as the f3-glucuronidase in cleaving the glucuronide bond from 
~-9-THC before extraction. 
With no ~-9-THC to use for the comparison of pH environments for the 
extraction, these two extractions were compared using the internal standard, ~-9-THC-
D3. ~-9-THC-D3 could be used because it was not conjugated in the urine and therefore 
did not have to be freed by use of the NaOH or f3-glucuronidase. The deuterated internal 
standard was added to each of the samples prior to the extraction process in equal 
concentrations so that the ~-9-THC could be quantitated. When the area and height of 
the base ion for the internal standard was compared for the acidic and alkaline 
extractions, the alkaline extraction using NaOH was shown to be more efficient. The 
basic extraction had a larger mean for both area and height; it had smaller standard 
deviations than the acidic extraction, and lower estimated standard errors for the area and 
height. For the extraction of the internal standard, the basic extraction using the NaOH 
proved to be the best option, even though it was completely inefficient for the recovery of 
~-9-THC. 
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When data from both extractions were statistically compared using a two-tail t 
test, the two extractions of L1-9-THC-D3 proved to be significantly different. The 
calculated t ratios for the test should have fallen below 1.98 for 120 degrees of freedom 
for a .05 level of significance in order for the two procedures to be considered statistically 
not different. For the comparison of the data from the areas ofthe acidic and basic 
extraction, t (.05) c1oo) = 2.153, and for the heights, t (0.5) (100) = 17.357. These t ratios 
showed that the two procedures were significantly different and that the basic extraction 
was more efficient in the extraction of the internal standard. 
Because of the absence of Li-9-THC in the first experiment, the only data obtained 
concerned the internal standard. In order to completely determine if an acidic extraction 
was as efficient as an alkaline extraction, Li-9-THC would need to be recovered in each. 
It was decided that the best way to complete this was to treat all samples to be compared 
with 13-glucuronidase to first cleave the glucuronide bond. Another set of samples were 
then treated with 13-glucuronidase, identical to the acidic process, but were made alkaline 
using NaOH prior to extraction. 
These samples were analyzed and Li-9-THC recovered from them. The basic 
extraction using 13-glucuronidase showed recovery in 41 of the 50 urine samples and the 
Li-9-THC was quantitated in 34 ofthe samples. Now that two different pH extractions 
yielded recovery of Li-9-THC, the effect of pH on extraction efficiency could be 
determined. While the statistical data for the two extractions were close in value, the 
mean for the area and height of the acidic extraction was higher than the basic. However, 
the standard deviations for the basic extraction were lower than the acidic, and the 
estimated standard error for the basic extraction was lower than the acidic extraction. 
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After the initial calculations for both the area and the height for the basic and acid 
extractions were done, a two-tailed t test was performed for the area and height of the 
base ion for ~-9-THC. A t ratio for the area and height for the two methods was 
calculated and compared to the t value of 1.980 from the table for a .05 level of 
significance for 120 degrees of freedom. For the area, t (.05) ( IOO) = 0.277 and for the 
height, t (.o5) ( IOO) = 0.283. Both of these values fall well below the accepted value of 
1.980 and were determined to not be significantly different. This showed that whether 
the extraction was completed at an acidic or alkaline pH, it was still efficient for the 
extraction of ~-9-THC from urine. 
A calibration curve was made using direct standards in order to determine the 
actual concentration of ~-9-THC recovered by each method. Once these concentrations 
were determined, they too were analyzed for statistical difference. For the acidic 
extraction, 29 of the urine samples were able to be quantitated and using the basic 
extraction process, 34 of the samples were able to be quantitated. The mean 
concentration for the acidic extraction (3.08 ng/mL), however, was higher than the mean 
concentration (2.94 ng/mL) from the basic extraction even though 5 fewer samples were 
able to be quantitated. The standard deviation and standard error for the acidic 
extractions were slightly higher than the basic extraction' s standard deviation and 
standard error. For the acidic extraction, the standard deviation was 3.43 and for the 
basic, 3.30. Standard error for the acidic and basic extractions was 0.42 and 0.40, 
respectively. 
Using the above data a two-tail t test was performed for a 0.5 level of significance 
for 120 degrees of freedom. At ratio was determined and compared to the 1.980 value. 
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I(.OS) ( IOO) = 0.241 fell below the acceptable limit and the two extractions were again 
proven to not be significantly different. Since no significant difference between the two 
methods was found using the area or height of the base 8.-9-THC ion fragment or by 
using the concentrations found when using each extraction, the methods are considered to 
both be efficient when extracting 8.-9-THC from urine. 
The average percent recovery of both of the procedures was calculated in addition 
to the statistical comparisons. Using the average area and average height of the 8.-9-
THC-D3 recovered for both the acidic and basic extractions, percent recovery was 
calculated. The internal standard was used to determine percent recovery because the 
same concentration was added to all of the samples and to the standards. The 8.-9-THC 
would have not produced as accurate of results because tl;le concentrations varied from 
sample to sample and would require finding a sample with the exact concentration as one 
of the standards. Using the internal standard recovery from a standard that was directly 
injected as the theoretical recovery, the average percent recovery from the acidic and 
basic extractions could be determined. The average of the areas and heights from each 
method was used because ofthe wide range of value between the lowest and highest 
recoveries from the samples. A percent recovery of 96.61 % and 103 % was determined 
for the height and area of the acidic extraction. For the basic extraction, a percent 
recovery of96.50% and 100% was calculated for the height and area, respectively. The 
acidic extraction yielded more than 100 % for the recovery of the area; this can be 
attributed to the slight change in the instrument's response at different times. The acidic 
extraction showed a slightly higher percent yield than the basic extraction, but overall the 
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two both had high percent yields and again both proved to be efficient in the extraction of 
L1-9-THC from urine. 
This research compared the efficiency of two methods of breaking the 
glucuronide bond as well as the efficiency of completing the extraction at an acidic pH. 
According to the literature (Kemp, et al., 1995), 13-glucuronidase from the E. coli bacteria 
works best when hydrolyzing the glucuronide bond from L1-9-THC. The research 
conducted here completely agreed with the literature regarding the best option for 
cleaving the bond. Using the NaOH was not just less efficient than the 13-glucuronidase; 
it yielded no results at all for the extraction of L1-9-THC from the urine samples. 
While the findings of this research are consistent with the literature concerning 
the best process for freeing L1-9-THC, the time used for the. enzymatic process in this 
research is much less than that ofthe literature. Kemp et al. (1995) reported allowing the 
samples to incubate overnight while this procedure allowed the urine samples to incubate 
for just 1.5 hours at the same temperature as from the literature. The less time used for 
incubation greatly reduces the time for the extraction process and makes this a desirable 
technique for laboratories with a high volume of samples. 
Literature describes the extraction of L1-9-THC at an alkaline pH only (Kemp et 
al., 1995; Huestis, 2006). An acidic extraction of the compound has not yet been used. 
L1-9-THC is not an acidic compound. It has a pKa of 10.6 (Clarke 's Isolation and 
Identification of Drugs, 1986) which means that it should be extracted best at an alkaline 
pH. To extract the L1-9-THC at an alkaline pH after the use of the 13-glucuronidase would 
mean having to add a strong basic solution to each sample. This creates an extra step in 
the extraction process which means more time and more consumables used. 
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Since the extraction is equally efficient when performed at an acidic pH as an 
alkaline pH as shown through this research, the omission of this step would save time 
during the extraction as well as the time spent making the solution initially. The 
omission of this step would also mean that less alkaline salt would be used. Since only a 
small amount of the basic solution can be used to increase the pH of the urine to an 
alkaline environment, the solution used must be highly concentrated. This means a large 
amount of the salt is used. Not performing this step would mean saving money on 
chemicals, saving time spent making the solution as well as saving an extra step during 
the extraction process all while still obtaining correct results. 
Research similar to this study (Manno et al. , 200 1; Huestis et al., Blood 
Cannabinoids I, 1992) has been conducted in controlled .situations where the marijuana 
users are brought into a laboratory setting and allowed to smoke marijuana cigarettes 
according to a computerized procedure. In these studies, the percent of ~-9-THC in each 
marijuana cigarette was known by the researchers and the smoking process computerized. 
For the smoking process, the participant is prompted when to inhale, how long to hold the 
smoke, when to exhale, and how long to wait until the next inhalation by a computer. 
The process is very standardized in order to establish consistency for these controlled 
studies. 
In a real-life setting, users do not smoke marijuana according to a protocol; 
inhalation, exhalation, and the occurrence of the next inhale are all at random and 
dependent on the user. The percent of ~-9-THC in the marijuana is also not known. 
Since the samples used during this research were all from marijuana users who smoked 
by their own means, the peak concentration of ~-9-THC found in the urine was shifted to 
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an earlier time than literature reported. Controlled studies such as the ones performed by 
Manno et al. (200 1) and Huestis et al. (Blood Cannabinoids I, 1992), reported the peak /J.-
9-THC concentration in urine to be around 2 hours after smoking ceased. The research 
here showed the highest concentrations occurring between 30 minutes and 1.5 hours with 
the peak concentration time to be around 1 hour. This difference can be attributed to the 
smoking procedures for controlled studies versus real-life smoking procedures. An 
unknown percent of /J.-9-THC in the marijuana used as well as how the user smoked 
could very well account for the earlier peak concentration of /J.-9-THC in the urine 
samples. 
Another possible explanation for the quicker peak concentration time is the 
activity of the user while smoking. If the person who ingested marijuana is in a 
laboratory they will not be as active as a user who used marijuana in a social situation. 
Moving around may increase excretion of the drug and will therefore cause it to enter the 
urine more rapidly. More research will need to be conducted to further explain the earlier 
peak concentration found when using samples from smokers not under a controlled study. 
Also, when marijuana users in real-life situations ingest marijuana, it is in combination 
with ethanol. Ethanol is a natural diuretic and could possibly cause the /J.-9-THC to be 
excreted quicker by these users. 
This research focused on three different questions concerning the extraction of /J.-
9-THC from urine: which treatment, either NaOH or r3-glucuronidase, would best 
hydrolyze the glucuronide bond, could the extraction be completed at an acidic pH and 
still yield the expected concentrations of /J.-9-THC, and finally, does peak concentrations 
from smokers in uncontrolled studies agree with that reported by literature? This 
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research proves to be consistent with the literature when determining the best method for 
breaking the glucuronide bond; it shows that a step of the extraction process can be 
omitted and not effect the yield of ~-9-THC, and it offers insight to the time versus urine 
concentration of real-life marijuana users. 
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I. Project Goals: 
-To analyze urine samples from individuals who use marijuana for the presence of 
~-9-Tetrahydrocannabinol. Variations in the habits of the donors, such as how often the 
donors smoke and the time period since they last smoked, will be compared to the 
concentration of ~-9-Tetrahydrocannabinol during the analytical process. 
II. Protocols 
Samples to be collected 
The principal investigator's laboratory will not be involved in the collection of any of the 
human samples. 
111 Urine samples will be obtained from a minimum of 50 anonymous, volunteer 
donors who are at least 21 years of age. Any sample suspected of being donated 
by a volunteer under 21 years old will be discarded immediately. 
• Each participant will receive a plastic urine specimen cup in which his/her sample 
will be collected. This participant will receive the urine specimen cup in a brown 
paper bag from a third party individual so that he or she remains anonymous to 
the principle investigator. The third party will be expressly instructed not to give a 
collection kit to anyone under 21 years of age. 
• The individual receiving the collection kit from the third party may give the kit to 
another volunteer donor, provided they were informed by the third party that no 
one under the age of 21 shall participate in this study. 
111 The collection of the urine by the volunteer donor will be completed in a private 
place chosen by the donor. The overall procedure will take approximately 10 
minutes to complete. 
• The donor will provide the following information on a provided strip of paper: 
heavy smoker (6-7 days per week), medium smoker (3-5 days per week), light 
smoker (1- 2 days per week), or recreationally (1-3 times per month.) 
• In addition to the number of times a subject smokes per week or month, the time 
period between when he/she last smoked and the time of collection will also be 
recorded by the participant on the data form. 
11 The manner in which the participant smoked marijuana will be recorded on the 
data form provided. 
11 No other identifying information will be collected on the urine specimens 
donated. This project is for research purposes only and any findings will not be 
used against the participants under any circumstances. 
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11 As samples are received, they will be numbered and categorized by the committee 
chair so that the category of the sample remains unknown to the principle 
investigator so as not to bias the principle investigator during any of the analytical 
process. (See categories stated above.) 
11 Urine samples will be kept in a locked freezer in a locked, limited access 
laboratory for six months following project completion and then discarded in a 
manner that meets biohazard and safety regulations. 
Subject Population 
11 Subject population is not a variable within the study and therefore sample 
donations will be accepted from donors of both genders and all ethnic 
backgrounds. 
Ill Control samples will also be collected from 2 individuals known not to have 
ingested marijuana by any method within the past year 
Procedure and Research Locations 
11 Samples will be placed in a plain paper bag and dropped off by participants into 
an unmarked box located at Arthell Kelley Hall. 
11 Analysis of these samples will take place at The University of Southern 
Mississippi, School of Criminal Justice, Arthell Kelley Hall research laboratory. 
III. Benefits 
111 There are no benefits for individuals participating in this research project. 
IV. Risk 
Sampling Risk 
II There are no risks involved during the collection of the samples by the volunteers. 
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Ill Volunteers will be released from the study as soon as the urine sample is collected 
or delivered. 
l.tl Final data and chromatograms will be maintained in a locked desk in the 
committee chair's office for a period of 6 months. Data will be shredded at the 
end of the 6 months and then discarded. 
Confidentially and Anonymity 
Ill No identifying information will be collected during the sample collection process. 
l.tl Samples will be stored in a secure area at Arthell Kelley Hall. They will be 
placed in a locked freezer located in a locked, limited access laboratory. Only the 
principle investigator and committee chair have access to the laboratory. 
V. Informed Consent 
l.tl Each participant will receive a letter along with the urine specimen cup that 
explains what he or she should and should not place on the specimen cup as well 
as where and how to bring the sample. (A copy of this letter is enclosed.) No 
signature, participant number, or any other identifying information will be 
required for the volunteer to divulge due to the anonymity of the project. 
APPENDIX C 
INFORMED CONSENT 
Participation in this research project is completely voluntary and donors may 
withdraw at any time without penalty or prejudice and no personal information shall be 
disclosed by the principle investigator of the project. The procedure will take 
approximately 10 minutes for the volunteer to void his or her bladder and to fill out the 
form. 
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Samples collected will be used for the analysis of L1-9-THC following extraction 
of the urine samples. All urine samples will be stored in a locked freezer in a locked 
laboratory. The data obtained from the samples will be kept in the committee chair's 
office in a locked cabinet during the project. Both the urine samples and the data will be 
discarded 6 months after the project is complete. 
• Urine specimen cups, brown paper bags, tamper-prooftape, and the data form are 
provided for the collection of the sample. 
• After collecting the urine sample in the provided urine specimen cup, the 
participant should place one of the following labels on the provided data form to 
indicate the number of times per week that he/she smokes marijuana: heavy (6-7 
days), medium (3-5 days), light (1-2 days), or recr:eationally (1-3 times a month). 
• The time that has elapsed since the donor last smoked should also be placed on 
the data form along with information concerning the manner in which the 
participant smoked marijuana (i.e. pipe, bong, blunt, etc.). 
111 The participant should NOT write his/her name, initials, or any other identifying 
information on the data form. 
• Once these indications have been marked on the data form, it and the urine 
collection cup should be placed in the brown paper bag provided and the bag 
sealed with tamper-proof evidence tape. NO markings should be placed on this 
bag. 
• After these steps have been taken, donors should either bring his/her sample or 
have someone else deliver his/her sample to Arthell Kelley Hall at The University 
of Southern Mississippi. The donor' s brown paper bag containing the urine 
sample will be placed in an unmarked brown box in the front lobby next to the 
receptionist's desk. 
Questions concerning the research, at any time during or after the project, 
should be directed to Ashlyn Harmon at 225.937.7952 or 601.266.5212. This project 
and this consent form have been reviewed by the Human Subjects Protection 
Review Committee, which ensures that research projects involving human subjects 
follow federal regulations. Any questions or concerns about rights as a research 
participant should be directed to the Chair of the Institutional Review Board, The 
University of Southern Mississippi, 118 College Drive #5147, Hattiesburg, MS 
39406-0001, (601) 266-6820. 
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0 Please indicate the number of times you smoke marijuana in the following blank. 
0 How many hours has it been since you last smoked marijuana? ____ _ 
0 Were you smoking marijuana at the time of urine collection? ____ _ 
0 Which manner or apparatus did you use to smoke marijuana? ____ _ 
***DO NOT PLACE ANY IDENTIFYING INFORMATION ON THE 
SPECIMEN CUP, 
PAPER BAG OR THIS PAPER. 
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